Case Report
Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine
Table 1
Laboratory parameters of the patient before the treatment (admission to the hospital and 1 week after the 2nd vaccination) and after the treatment.
| Laboratory parameters | Before the treatment | After the treatment |
| Urea (mg/dL) | 91 | 35 | Creatinine (mg/dL) | 2.4 | 0.64 | Sodium (mmol/L) | 134 | 141 | Potassium (mmol/L) | 4.66 | 4.67 | Blood gas pH | 7.36 | 7.40 | Serum albumin (g/dL) | 1.9 | 2 | Total protein (g/dL) | 5 | 5.5 | 24-hour urine protein (mg/day) | 15935 | 67 | Alanine aminotransferase (U/L) | 14 | 31 | Aspartate aminotransferase (U/L) | 27 | 49 | WBC (/mm3) | 9400 | 6500 | Hemoglobin (g/dL) | 11.2 | 11.4 | Platelet (/mm3) | 314000 | 310000 | CRP (mg/L) | 108.0 | 5.41 | LDL (mg/dL) | 248 | 284 | Triglyceride (mg/dL) | 336 | 334 | Erythrocyte sedimentation rate (mm/h) | 72 | 20 |
|
|